Golden State Equity Partners Sangamo Therapeutics, Inc Transaction History
Golden State Equity Partners
- $402 Million
- Q4 2023
A detailed history of Golden State Equity Partners transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Golden State Equity Partners holds 201,225 shares of SGMO stock, worth $80,490. This represents 0.03% of its overall portfolio holdings.
Number of Shares
201,225
Previous 166,265
21.03%
Holding current value
$80,490
Previous $99,000
9.09%
% of portfolio
0.03%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding SGMO
# of Institutions
137Shares Held
100MCall Options Held
35.5KPut Options Held
65.8K-
Wasatch Advisors Inc Salt Lake City, UT20.1MShares$8.05 Million0.07% of portfolio
-
Armistice Capital, LLC New York, NY17MShares$6.78 Million0.15% of portfolio
-
Black Rock Inc. New York, NY13.3MShares$5.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$4.88 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA4.94MShares$1.98 Million0.01% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $62.6M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...